.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
UBS
Colorcon
Deloitte
Cipla
Boehringer Ingelheim
US Army
AstraZeneca
Merck
Daiichi Sankyo

Generated: September 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 206336

« Back to Dashboard
NDA 206336 describes BALSALAZIDE DISODIUM, which is a drug marketed by West-ward Pharms Int, Mylan, Par Pharm Inc, and Apotex Inc, and is included in four NDAs. It is available from nine suppliers. Additional details are available on the BALSALAZIDE DISODIUM profile page.

The generic ingredient in BALSALAZIDE DISODIUM is balsalazide disodium. There are ten drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the balsalazide disodium profile page.

Summary for NDA: 206336

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Inflammatory Bowel Disease Agents

Pharmacology for NDA: 206336

Ingredient-typeAminosalicylic Acids

Suppliers and Packaging for NDA: 206336

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BALSALAZIDE DISODIUM
balsalazide disodium
TABLET;ORAL 206336 ANDA Par Pharmaceutical Inc. 49884-367 49884-367-05 500 TABLET in 1 BOTTLE (49884-367-05)
BALSALAZIDE DISODIUM
balsalazide disodium
TABLET;ORAL 206336 ANDA Par Pharmaceutical Inc. 49884-367 49884-367-13 180 TABLET in 1 BOTTLE (49884-367-13)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1.1GM
Approval Date:Sep 8, 2015TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
QuintilesIMS
Cerilliant
Queensland Health
Harvard Business School
Baxter
US Army
Merck
Chubb
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot